| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | C01EB17 |
| UNII | 3H48L0LPZQ |
| EPA CompTox | DTXSID2048240 |
| InChI Key | ACRHBAYQBXXRTO-OAQYLSRUSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H36N2O5 |
| Molecular Weight | 468.59 |
| AlogP | 3.31 |
| Hydrogen Bond Acceptor | 6.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 60.47 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 34.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker | BLOCKER | DailyMed PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Voltage-gated ion channel
Cyclic nucleotide-regulated channel
|
- | - | - | - | 47-49 |
|
Protein: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Description: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Organism : Homo sapiens Q9Y3Q4 ENSG00000138622 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 85966 |
| ChEMBL | CHEMBL471737 |
| DrugBank | DB09083 |
| DrugCentral | 3312 |
| FDA SRS | 3H48L0LPZQ |
| Guide to Pharmacology | 2357 |
| PharmGKB | PA166123415 |
| PubChem | 132999 |
| SureChEMBL | SCHEMBL23472 |
| ZINC | ZINC000003805768 |